• 원예과학기술지
• /
• 제28권5호
• /
• pp.857-863
• /
• 2010

기생초 꽃의 생리활성을 평가하여 천연물 유래 기능성 소재를 개발하기 위하여 에탄올 추출물 및 용매분획물의 항산화활성, ACE 저해활성, ${\alpha}$-glucosidase 억제능, 항염활성 및 항암활성을 측정하였다. 에탄올 추출물의 DPPH radical 소거 활성($IC_{50}$)과 ABTS radical 소거활성은 각각 $0.100mg{\cdot}mL^{-1}$ 및 3.427 AEAC였으며, 용매분획물 중 ethyl acetate 분획물이 각각 $0.034mg{\cdot}mL^{-1}$ 및 15.785AEAC으로 가장 높았으며, ACE 저해활성 및 ${\alpha}$-glucosidase 억제활성도 각각 40.96% 및 $0.125mg{\cdot}mL^{-1}$로 ethyl acetate 분획물이 우수하였다. 또한 에탄올 추출물, chloroform 및 ethyl acetate 분획물에서 세포독성 없이 효과적으로 NO의 생성을 억제하였고, 대장암 세포주에 대한 에탄올 추출물, n-hexane, chloroform 및 ethyl acetate 분획물의 $IC_{50}$값은 각각 0.208, 0.041, 0.142 및 $0.107mg{\cdot}mL^{-1}$으로 우수한 증식억제효과를 보였다. 이러한 결과를 종합하여 볼 때, 기생초 꽃의 우수한 생리활성을 이용한 기능성 소재로의 활용이 가능 할 것으로 판단된다.

• 한국지역사회생활과학회지
• /
• 제26권1호
• /
• pp.103-113
• /
• 2015

This study examines the effects of Korean Crataegi fructrus(KCF) and Chinese Crataegi fructrus(CCF) on the antioxidative activity and antiproliferation of human cancer cells(HCT-116 human colon, Hep G2 human liver, and A549 human lung cancer cells). The total polyphenol and flavonoid contents, and antioxidative index of the Crataegi fructrus ethanol extracts were significantly higher in KCF than in CCF. The DPPH radical-scavenging activity of the KCF ethanol extract was 82.26%(1000 ppm), and that of the CCF ethanol extract was 77.64%. Antiproliferation effects of 80% ethanol extracts of KCF and CCF on human cancer cells(HCT-116, Hep G2 and A549) increased in a dose-dependent manner. Inhibitory effects of KFC on HCT-116 and A549 cells were greater than those of CCF. The results suggest that ethanol extracts of Crataegi fructrus have antioxidative and hyperplasia inhibition effects on human cancer cells.

• 한국식품영양과학회지
• /
• 제39권1호
• /
• pp.36-41
• /
• 2010

상황버섯, 영지버섯 및 노루궁뎅이버섯 균사체로 발효된 인삼추출물이 암세포증식에 미치는 영향을 살펴보기 위하여 위암세포(MKN-45), 대장암세포(HCT116), 유방암세포(MCF-7), 폐암세포(NCIH460), 전립선암세포(PC-3) 및 간암세포(HepG2)에 농도별(0.25～1.5 mg/mL)로 처리하여 암세포 성장억제율을 측정하였다. 전립선암 세포에서의 암세포 증식억제 효과는 영지버섯 균사체발효 인삼추출물이 1.5 mg/mL 농도에서 3.07%로 가장 낮은 생존율을 나타내었으며, 상황버섯 균사체발효 인삼추출물이 35.05%, 노루궁뎅이버섯 균사체발효 인삼추출물이 44.29%의 생존율을 보였다. 폐암세포에 대한 세 가지 버섯균사체발효 인삼추출물의 1.5 mg/mL 농도에서 영지버섯 균사체발효 인삼추출물은 5.31%로 우수한 항암활성을 나타낸 반면, 상황버섯 균사체발효 인삼추출물이 53.52%, 노루궁뎅이버섯 균사체발효 인삼추출물이 35.27%의 생존율을 나타내었다. 이러한 결과로부터 영지버섯 균사체로 발효시킨 인삼추출물이 다른 균사체 인삼발효물보다 다양한 암세포에 대한 성장억제 효과가 우수함을 확인할 수 있었다.

• 한국식품영양과학회지
• /
• 제38권11호
• /
• pp.1478-1484
• /
• 2009

목련 꽃 에탄올 추출물과 용매분획물에 대한 항산화활성, 항암활성 및 항염증활성을 살펴본 결과는 다음과 같다. 목련꽃 추출물의 총 폴리페놀과 플라보노이드 함량은 216.14 및 86.93 mg/g이었고, DPPH법에 의한 항산화활성의 $IC_{50}$값은 0.232 mg/mL이었으며, 용매분획물 중 에틸아세테이트 분획물이 우수한 항산화활성을 보였다($IC_{50}$: 0.197 mg/mL, AEAC: 0.90 mg AA eq/100 mg). 또한 에탄올 추출물 및 용매분획물은 대장암, 폐암 그리고 간암세포에 대하여 선택적으로 낮은 농도에서 증식억제효과를 보였으며, 클로로포름 분획물은 리포폴리사카라이드 유도 일산화질소 생성 저해효과를 보였다($IC_{50}$: 49.5 $\mu$g/mL).

• 한국식품영양과학회지
• /
• 제43권5호
• /
• pp.682-689
• /
• 2014

본 연구는 모시잎의 건조방법에 따른 항산화 및 암세포 증식억제효과를 비교 분석하였다. 80% 에탄올로 추출한 열풍건조 및 동결건조 모시잎의 총 폴리페놀 함량은 건조방법에 따른 유의적 차이를 보이지 않았다. 반면 총 플라보노이드 함량은 열풍건조 모시잎이 동결건조 모시잎에 비하여 유의하게 높게 나타났다. 1,000 ppm에서 열풍건조 및 동결건조 모시잎의 DPPH 라디칼 소거능은 각각 77.74%와 77.29%의 비슷한 라디칼 소거능을 보였으며, Rancimat으로 측정한 열풍건조 및 동결건조 모시잎의 항산화지수는 각각 1.38과 1.32로 BHT, BHA 및 비타민 C에 비해서는 낮았으나 시료를 미첨가한 음성대조군보다는 높은 항산화력을 보였다. 위암(AGS), 간암(Hep G2) 및 폐암(A549) 세포에 대한 모시잎 에탄올 추출물의 암세포 증식 억제효과를 알아본 결과, 열풍건조 및 동결건조 모시잎 에탄올 추출물의 농도가 증가할수록 암세포의 증식 억제 활성은 농도 의존적으로 증가되었다. 건조방법에 따른 항암활성은 비슷한 경향이었으며 가장 높은 농도인 $800{\mu}g/mL$에서 80% 이상의 간암 및 폐암세포의 증식 억제 활성을 보였고, 위암세포에서는 75%이상의 증식 억제 활성을 보였다. 이상의 결과 열풍건조 및 동결건조 모시잎 에탄올 추출물은 in vitro에서 항산화효과와 암세포의 증식 억제효과를 보였고, 건조방법에 따른 모시잎 에탄올 추출물의 항산화 활성 및 암세포 증식 억제 활성은 비슷한 경향으로 나타났다.

• Advances in Traditional Medicine
• /
• 제6권4호
• /
• pp.286-292
• /
• 2006

In this study, we evaluated the antiproliferative effects of Panax notoginseng, ginsenoside Rb1, and notoginsenoside R1 in the human breast carcinoma MCF-7 cell line. Our results indicated that both Panax notoginseng radix extract (NRE) and Panax notoginseng rhizoma extract (NRhE) possess significant antiproliferative activities in MCF-7 cells. Compared to control group (100%), at the concentrations of 0.05, 0.5, and 1.0 mg/ml NRE, cell growth was concentration-dependently reduced to 81.0 ${\pm}$ 6.1 (P < 0.01), 34.2 ${\pm}$ 4.8 (P < 0.001), and 19.3 ${\pm}$ 1.9 (P < 0.001), respectively. Similar results with NRhE at concentrations of 0.5 and 1.0 mg/ml were obtained in these MCF-7 cells. To identify the responsible chemical constituent, we tested the antiproliferation effects of two representative saponins, ginsenoside Rb1 and notoginsenoside R1, on the MCF-7 cells. The data showed that ginsenoside Rb1 was endowed with antiproliferative properties, while notoginsenoside R1 did not have an inhibitory effect in the concentrations tested. Our studies provided evidence that Panax notoginseng extracts and ginsenoside Rb1 may be beneficial, as adjuvants, in the treatment of human breast carcinoma.

• 대한의생명과학회지
• /
• 제11권2호
• /
• pp.175-183
• /
• 2005

The two major isoflavones in soy, genistein and daidzein, are well known to prevent hormone-dependent cancers by their anti estrogenic activity. The exact molecular mechanisms for the protective action are, however, not provided yet. It has been reported that genistein and daidzein have a potential anticancer activity through their antiproliferative effect in many hormone-dependent cancer cell lines. Transforming growth $factor-\beta1(TGF-\beta1)$ has also been found to have cell growth inhibitory effect, especially in mammary epithelial cells. This knowledge led to a hypothetical mechanism that the soy isoflavones-induced growth inhibitory effect can be derived from the regulation of $TGF-\beta1$ and $TGF-\beta$ receptors. In order to test this hypothesis, the effects of the soy isoflavones at various concentrations and periods on the expression of $TGF-\beta1$and $TGF-\beta$ receptors were investigated by using Northern blot analysis in human breast carcinoma epithelial cell lines, an estrogen receptor positive cell line (MCF-7) and an estrogen receptor negative cell line (MDA-MB-231). As a result, only genistein has shown a profound dose-dependent effect on $TGF-\beta1$ expression in the $ER^+$ cell line within the range of doses tested, and the expression levels are correspondent to their inhibitory activities of cell growth. Moreover, daidzein showed down-regulated $TGF-\beta1$ expression at a low dose, the cell growth proliferation was promoted at the same condition. Therefore, antiproliferative activity of the soy isoflavones can be mediated by $TGF-\beta1$ expression, and the effects are mainly, if not all, occurred by ER dependent pathway. The expression of $TGF-\beta$ receptors was induced at a lower dose than the one for $TGF-{\beta}1$ induction regardless of the presence of ER, and the expression patterns are similar to those of the cell growth inhibition. These results indicated that the regulation of $TGF-\beta$ receptor expression as well, prior to $TGF-\beta1$ expression, may be involved in the antiproliferative activity of soy isoflavones. Little or no expression of $TGF-\beta$ receptors was found in the MCF-7 and MDA-MB-231 cells, suggesting refractory properties of the cells to growth inhibitory effect of the $TGF-\beta$. The soy isoflavones can seemingly restore the sensitivity of growth inhibitory responses to $TGF-\beta1$ by re-inducing $TGF-\beta$ receptors expression. In conclusions, our findings presented in this study show that the antitumorigenic activity of the soy isoflavones could be mediated by not only $TGF-\beta1$induction but $TGF-\beta$ receptor restoration. Thus, soy isoflavones could be good model molecules to develop new nonsteroidal antiestrogenic chemopreventive agents, associated with, regulation of $TGF-\beta$ and its receptors.

• Biomolecules & Therapeutics
• /
• 제16권3호
• /
• pp.286-292
• /
• 2008

Strawberry is widely consumed in diet and has been attracted much attention due to its potential for human health benefits. Strawberry contains a diverse range of phytochemicals but the biological activities with molecular mechanisms are poorly elucidated yet. In this study, the effects of the extracts of strawberry (Maehyang cultivar) on antioxidant, antiinflammatory, and antiproliferative potential against various cancer cells were investigated. The strawberry extracts (SE) of Maehyang cultivar showed 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical scavenging activities. In addition, SE inhibited the growth of human colon (HCT-116), lung (A549), stomach (SNU-638) and fibrosarcoma (HT-1080) cancer cells. The strawberry extracts also exhibited the inhibitory effect on lipopolysaccharide (LPS)-stimulated nitric oxide (NO) production and suppressed LPS-induced inducible nitric oxide synthase (iNOS) protein and mRNA expression in mouse macrophage RAW 264.7 cells. These findings suggest that the strawberry extracts (Maehyang cultivar) might have antioxidant, antiinflammotry, and anticancer activities.

• Archives of Pharmacal Research
• /
• 제27권10호
• /
• pp.1043-1047
• /
• 2004

Thirteen compounds were isolated from the $CH_2Cl_2$ fraction of Machilus thunbergii as phospholipase $C{\Upsilon}1\;(PLC{\Upsilon}1)$ inhibitors. These compounds were identified as nine lignans, two neolignans, and two flavans by spectroscopic analysis. Of these, 5,7-di-O-methyl-3',4'-methylenated (-)-epicatechin (12) and 5,7,3'-tri-O-methyl (-)-epicatechin (13) have not been reported previously in this plant. In addition, seven compounds, machilin A (1), (-)-sesamin (3), machilin G (5), (+)-galbacin (9), licarin A (10), (-)-acuminatin (11) and compound 12 showed dose-dependent potent inhibitory activities against $PLC{\Upsilon}1$ in vitro with $IC_{50}$ values ranging from 8.8 to 26.0 ${\mu}M$. These lignans, neolignans, and flavans are presented as a new class of $PLC{\Upsilon}1$ inhibitors. The brief study of the structure activity relationship of these compounds suggested that the benzene ring with the methylene dioxy group is responsible for the expression of inhibitory activities against $PLC{\Upsilon}1$. Moreover, it is suggested that inhibition of $PLC{\Upsilon}1$ may be an important mechanism for an antiproliferative effect on the human cancer cells. Therefore, these inhibitors may be utilized as cancer chemotherapeutic and chemopreventive agents.

• Journal of Ginseng Research
• /
• 제40권1호
• /
• pp.62-67
• /
• 2016

Background: Ginseng, which is widely used in functional foods and as an herbal medicine, has been reported to reduce the proliferation of prostate cancer cells by mechanisms that are not yet fully understood. Methods: This study was designed to investigate the changes in ginsenoside content in ginseng after treatment with a microwave-irradiation thermal process and to verify the anticancer effects of the extracts. To confirm the anticancer effect of microwave-irradiated processed ginseng (MG), it was tested in three human prostate cancer cell lines (DU145, LNCaP, and PC-3 cells). Involvements of apoptosis and autophagy were assessed using Western blotting. Results: After microwave treatment, the content of ginsenosides Rg1, Re, Rb1, Rc, Rb2, and Rd in the extracts decreased, whereas the content of ginsenosides 20(S)-Rg3, 20(R)-Rg3, Rk1, and Rg5 increased. Antiproliferation results for the human cancer cell lines treated with ginseng extracts indicate that PC-3 cells treated with MG showed the highest activity with an half maximal inhibitory concentration of $48{\mu}g/mL$. We also showed that MG suppresses the growth of human prostate cancer cell xenografts in athymic nude mice as an in vivo model. This growth suppression by MG is associated with the inductions of cell death and autophagy. Conclusion: Therefore, heat processing by microwave irradiation is a useful method to enhance the anticancer effect of ginseng by increasing the content of ginsenosides Rg3, Rg5, and Rk1.